Santa Cruz, California-based Neurolutions designs non-invasive BCI technology for post-stroke therapy. Kandu Health, an Imperative Care subsidiary, aims to change the course of stroke recovery and post-acute care. It provides remote, multidisciplinary support after hospital discharge through a team of clinically licensed navigators and an app. Together, they aim to raise the standard of post-stroke rehabilitation.
Through this partnership, Kandu Health plans for its expert clinicians to support Neurolutions. They’ll provide clinical consultation and assessments of stroke survivors, determining who may benefit from the Neurolutions IpsiHand system.
“By combining our educational and clinical support with Neurolutions’ technology, we are taking a critical step forward in the way we approach and manage stroke recovery; allowing access and engagement from the comfort of a patient’s own home,” said Kirsten Carroll, CEO of Kandu Health. “This partnership is poised to offer patients an unprecedented level of care and support during an immensely vulnerable time of life.”
More about Kandu, Neurolutions and IpsiHand
IpsiHand, an FDA-cleared solution, enables non-invasive at-home rehabilitation for stroke survivors affected by chronic motor deficits. With Kandu, the collaboration can offer streamlined, expert clinical assessment for IpsiHand. This reduces the barriers to accessing the potentially life-changing technology.
The system uses brain-computer interface technology developed for chronic stroke patients with an impaired upper extremity. It helps them regain function after stroke.
Kandu says its expertise in tech-enabled solutions complements IpsiHand. The company’s integrated approach ensures support for stroke survivors, clinicians and care partners.
“The Neurolutions IpsiHand is a next-generation solution that meets stroke survivors where they are and empowers them through advanced thought-driven neurotechnology. By partnering with Kandu Health, we can ensure that individuals who most need the IpsiHand System are able to get it in a timely manner, and with the critical clinical support needed to optimize patient care,” said Leo Petrossian, CEO of Neurolutions, Inc. “We believe this will significantly expedite the recovery journey for countless stroke survivors.”
